KEGG   DRUG: Ibalizumab
Entry
D09575                      Drug                                   
Name
Ibalizumab (USAN/INN);
Ibalizumab-uiyk;
Trogarzo (TN)
  Abbr
IBA
Product
TROGARZO (Theratechnologies)
Sequence
(Heavy chain)
QVQLQQSGPE VVKPGASVKM SCKASGYTFT SYVIHWVRQK PGQGLDWIGY INPYNDGTDY
DEKFKGKATL TSDTSTSTAY MELSSLRSED TAVYYCAREK DNYATGAWFA YWGQGTLVTV
SSASTKGPSV FPLAPCSRST SESTAALGCL VKDYFPEPVT VSWNSGALTS GVHTFPAVLQ
SSGLYSLSSV VTVPSSSLGT KTYTCNVDHK PSNTKVDKRV ESKYGPPCPS CPAPEFLGGP
SVFLFPPKPK DTLMISRTPE VTCVVVDVSQ EDPEVQFNWY VDGVEVHNAK TKPREEQFNS
TYRVVSVLTV LHQDWLNGKE YKCKVSNKGL PSSIEKTISK AKGQPREPQV YTLPPSQEEM
TKNQVSLTCL VKGFYPSDIA VEWESNGQPE NNYKTTPPVL DSDGSFFLYS RLTVDKSRWQ
EGNVFSCSVM HEALHNHYTQ KSLSLSLGK
(Light chain)
DIVMTQSPDS LAVSLGERVT MNCKSSQSLL YSTNQKNYLA WYQQKPGQSP KLLIYWASTR
ESGVPDRFSG SGSGTDFTLT ISSVQAEDVA VYYCQQYYSY RTFGGGTKLE IKRTVAAPSV
FIFPPSDEQL KSGTASVVCL LNNFYPREAK VQWKVDNALQ SGNSQESVTE QDSKDSTYSL
SSTLTLSKAD YEKHKVYACE VTHQGLSSPV TKSFNRGEC
  Type
Peptide
Remark
ATC code: J05AX23
Product: D09575<US>
Efficacy
Antiviral, HIV fusion inhibitor, Anti-CD4 antibody
  Disease
HIV-1 infection [DS:H01563]
  Type
Monoclonal antibody
Comment
Treatment of HIV/AIDS in HIV-1 infected patients
Target
CD4 [HSA:920] [KO:K06454]
  Pathway
hsa03250  Viral life cycle - HIV-1
hsa04060  Cytokine-cytokine receptor interaction
hsa04514  Cell adhesion molecules
hsa04660  T cell receptor signaling pathway
hsa05170  Human immunodeficiency virus 1 infection
Structure map
map07053  Anti-HIV agents
Brite
Anatomical Therapeutic Chemical (ATC) classification [BR:br08303]
 J ANTIINFECTIVES FOR SYSTEMIC USE
  J05 ANTIVIRALS FOR SYSTEMIC USE
   J05A DIRECT ACTING ANTIVIRALS
    J05AX Other antivirals
     J05AX23 Ibalizumab
      D09575  Ibalizumab (USAN/INN) <US>
USP drug classification [BR:br08302]
 Antivirals
  Anti-HIV Agents, Other
   Ibalizumab
    D09575  Ibalizumab (USAN/INN)
Target-based classification of drugs [BR:br08310]
 Cell surface molecules and ligands
  Other cell surface molecules
   CD molecules
    CD4
     D09575  Ibalizumab (USAN/INN) <US>
Antimicrobials [BR:br08307]
 Antivirals
  Entry, fusion or uncoating inhibitor
   CD4 antibody
    D09575  Ibalizumab (USAN/INN) <US>
New drug approvals in the USA [br08319.html]
 New molecular entities and new therapeutic biological products
  D09575
New drug approvals in Europe [br08329.html]
 European public assessment reports (EPAR) authorised medicine
  D09575
New drug approvals in the USA, Europe and Japan [br08328.html]
 Approval dates by FDA, EMA and PMDA
  D09575
Other DBs
CAS: 680188-33-4
PubChem: 124490315
LinkDB

» Japanese version   » Back

DBGET integrated database retrieval system